1. The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
    Simona Miceska et al, 2023, Radiology and Oncology CrossRef
  2. Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis
    Ramy R. Saleh et al, 2022, Molecular Diagnosis & Therapy CrossRef
  3. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?
    Yun Ye et al, 2018, Medicine CrossRef
  4. Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer
    Estrid Høgdall et al, 2020, International Journal of Gynecologic Cancer CrossRef
  5. Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma
    Li-Jun Huang et al, 2018, Medicine CrossRef
  6. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
    Chen Zhang et al, 2021, Frontiers in Oncology CrossRef
  7. Prediction of the treatment response in ovarian cancer: a ctDNA approach
    Mina Sharbatoghli et al, 2020, Journal of Ovarian Research CrossRef
  8. New checkpoints in cancer immunotherapy
    Ling Ni et al, 2017, Immunological Reviews CrossRef
  9. Expression of STAT1 is positively correlated with PD-L1 in human ovarian cancer
    Fangran Liu et al, 2020, Cancer Biology & Therapy CrossRef

  10. Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients


    Anna Pawłowska et al, 2020, Cancer Management and Research CrossRef
  11. Expression and correlation of PD-L1 and HER2 in oesophageal squamous cell carcinoma
    Lulu Rong et al, 2024, Journal of Clinical Pathology CrossRef